Skip to main content
. 2003 Oct 14;89(8):1423–1427. doi: 10.1038/sj.bjc.6601329

Figure 1.

Figure 1

Survival curves of patients depending on (A) the presence or absence of postchemoembolisation syndrome (temperature >38.5°C, log rank=7.16, d.f.=1, P=0.0076) and (B) cytolysis (increase of serum AST of >100 U and more than 2 × prechemoembolisation value, log rank=0.2, d.f.=1, P=0.65).